Versartis Initiates Phase 2 Trial (VITAL) of Monthly Somavaratan in Adults With Growth Hormone Deficiency MENLO PARK, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing...
Holyoke Medical Center Selects QPID Health for Quality Initiative Hospital will use QPID Health technology to expedite review and improve care for behavioral health patients at risk for revolving emergency visits and readmissions Boston – September 2, 2015 – QPID...
ReShape Medical, Inc. Completes $38 Million Series D Financing Round Led by HealthCor Partners Management, L.P. and Endeavour Vision SA to Support U.S. Commercialization of ReShape™ Integrated Dual Balloon System Following Recent Approval by the FDA SAN CLEMENTE,...
Edge Therapeutics Reports Positive Top-Line Phase 1/2 NEWTON Trial Results of EG-1962 in Aneurysmal Subarachnoid Hemorrhage – Efficacy results show 60% favorable outcome vs. only 28% for standard of care – EG-1962 met primary and secondary safety endpoint...
Intarcia Announces New Top-Line Phase 3 Results for Investigational Therapy ITCA 650 in Type 2 Diabetes: Freedom-2 Comparative Trial Demonstrates Superior & Sustained Glucose Control and Weight Reduction vs Januvia Over 52 Weeks • Patients treated with ITCA 650...
WAVE Life Sciences Raises $66 Million in Series B Financing – Genetic medicine company continues to expand breadth of potential therapeutic applications for novel stereopure synthetic chemistry platform to treat rare diseases – Pipeline to span multiple...
Recent Comments